Literature DB >> 29491369

Endoplasmic reticulum and mitochondria in diseases of motor and sensory neurons: a broken relationship?

Nathalie Bernard-Marissal1, Roman Chrast2, Bernard L Schneider3.   

Abstract

Recent progress in the understanding of neurodegenerative diseases revealed that multiple molecular mechanisms contribute to pathological changes in neurons. A large fraction of these alterations can be linked to dysfunction in the endoplasmic reticulum (ER) and mitochondria, affecting metabolism and secretion of lipids and proteins, calcium homeostasis, and energy production. Remarkably, these organelles are interacting with each other at specialized domains on the ER called mitochondria-associated membranes (MAMs). These membrane structures rely on the interaction of several complexes of proteins localized either at the mitochondria or at the ER interface and serve as an exchange platform of calcium, metabolites, and lipids, which are critical for the function of both organelles. In addition, recent evidence indicates that MAMs also play a role in the control of mitochondria dynamics and autophagy. MAMs thus start to emerge as a key element connecting many changes observed in neurodegenerative diseases. This review will focus on the role of MAMs in amyotrophic lateral sclerosis (ALS) and hereditary motor and sensory neuropathy, two neurodegenerative diseases particularly affecting neurons with long projecting axons. We will discuss how defects in MAM signaling may impair neuronal calcium homeostasis, mitochondrial dynamics, ER function, and autophagy, leading eventually to axonal degeneration. The possible impact of MAM dysfunction in glial cells, which may affect the capacity to support neurons and/or axons, will also be described. Finally, the possible role of MAMs as an interesting target for development of therapeutic interventions aiming at delaying or preventing neurodegeneration will be highlighted.

Entities:  

Mesh:

Year:  2018        PMID: 29491369      PMCID: PMC5832431          DOI: 10.1038/s41419-017-0125-1

Source DB:  PubMed          Journal:  Cell Death Dis            Impact factor:   8.469


  160 in total

1.  Mitofusin2 mutations disrupt axonal mitochondrial positioning and promote axon degeneration.

Authors:  Albert L Misko; Yo Sasaki; Elizabeth Tuck; Jeffrey Milbrandt; Robert H Baloh
Journal:  J Neurosci       Date:  2012-03-21       Impact factor: 6.167

2.  Sigma-1R agonist improves motor function and motoneuron survival in ALS mice.

Authors:  Renzo Mancuso; Sara Oliván; Amaya Rando; Caty Casas; Rosario Osta; Xavier Navarro
Journal:  Neurotherapeutics       Date:  2012-10       Impact factor: 7.620

3.  Mitofusin 2 is necessary for transport of axonal mitochondria and interacts with the Miro/Milton complex.

Authors:  Albert Misko; Sirui Jiang; Iga Wegorzewska; Jeffrey Milbrandt; Robert H Baloh
Journal:  J Neurosci       Date:  2010-03-24       Impact factor: 6.167

4.  Axonal Charcot-Marie-Tooth disease patient-derived motor neurons demonstrate disease-specific phenotypes including abnormal electrophysiological properties.

Authors:  Mario A Saporta; Vu Dang; Dmitri Volfson; Bende Zou; Xinmin Simon Xie; Adijat Adebola; Ronald K Liem; Michael Shy; John T Dimos
Journal:  Exp Neurol       Date:  2014-10-30       Impact factor: 5.330

5.  Marinesco-Sjögren syndrome protein SIL1 regulates motor neuron subtype-selective ER stress in ALS.

Authors:  Audrey Filézac de L'Etang; Niran Maharjan; Marisa Cordeiro Braña; Céline Ruegsegger; Ruth Rehmann; Anand Goswami; Andreas Roos; Dirk Troost; Bernard L Schneider; Joachim Weis; Smita Saxena
Journal:  Nat Neurosci       Date:  2015-01-05       Impact factor: 24.884

6.  In silico analysis of SIGMAR1 variant (rs4879809) segregating in a consanguineous Pakistani family showing amyotrophic lateral sclerosis without frontotemporal lobar dementia.

Authors:  Muhammad Ikram Ullah; Arsalan Ahmad; Syed Irfan Raza; Ali Amar; Amjad Ali; Attya Bhatti; Peter John; Aisha Mohyuddin; Wasim Ahmad; Muhammad Jawad Hassan
Journal:  Neurogenetics       Date:  2015-07-24       Impact factor: 2.660

7.  Dysfunction in endoplasmic reticulum-mitochondria crosstalk underlies SIGMAR1 loss of function mediated motor neuron degeneration.

Authors:  Nathalie Bernard-Marissal; Jean-Jacques Médard; Hamid Azzedine; Roman Chrast
Journal:  Brain       Date:  2015-02-11       Impact factor: 13.501

8.  Mitofusin 2 tethers endoplasmic reticulum to mitochondria.

Authors:  Olga Martins de Brito; Luca Scorrano
Journal:  Nature       Date:  2008-12-04       Impact factor: 49.962

Review 9.  Mitochondria-associated ER membranes in Alzheimer disease.

Authors:  Eric A Schon; Estela Area-Gomez
Journal:  Mol Cell Neurosci       Date:  2012-08-24       Impact factor: 4.314

10.  ER-mitochondria associations are regulated by the VAPB-PTPIP51 interaction and are disrupted by ALS/FTD-associated TDP-43.

Authors:  Radu Stoica; Kurt J De Vos; Sébastien Paillusson; Sarah Mueller; Rosa M Sancho; Kwok-Fai Lau; Gema Vizcay-Barrena; Wen-Lang Lin; Ya-Fei Xu; Jada Lewis; Dennis W Dickson; Leonard Petrucelli; Jacqueline C Mitchell; Christopher E Shaw; Christopher C J Miller
Journal:  Nat Commun       Date:  2014-06-03       Impact factor: 14.919

View more
  24 in total

Review 1.  Biological roles of the B cell receptor-associated protein 31: Functional Implication in Cancer.

Authors:  Mwichie Namusamba; Zhi Li; Qi Zhang; Changli Wang; Tianyi Wang; Bing Wang
Journal:  Mol Biol Rep       Date:  2021-01-13       Impact factor: 2.316

2.  Altered interplay between endoplasmic reticulum and mitochondria in Charcot-Marie-Tooth type 2A neuropathy.

Authors:  Nathalie Bernard-Marissal; Gerben van Hameren; Manisha Juneja; Christophe Pellegrino; Lauri Louhivuori; Luca Bartesaghi; Cylia Rochat; Omar El Mansour; Jean-Jacques Médard; Marie Croisier; Catherine Maclachlan; Olivier Poirot; Per Uhlén; Vincent Timmerman; Nicolas Tricaud; Bernard L Schneider; Roman Chrast
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-18       Impact factor: 11.205

3.  In Vitro Nociceptor Neuroplasticity Associated with In Vivo Opioid-Induced Hyperalgesia.

Authors:  Eugen V Khomula; Dioneia Araldi; Jon D Levine
Journal:  J Neurosci       Date:  2019-07-12       Impact factor: 6.167

4.  Preventing Axonal Sodium Overload or Mitochondrial Calcium Uptake Protects Axonal Mitochondria from Oxidative Stress-Induced Alterations.

Authors:  Bimala Malla; Carmen Infante-Duarte; Rebecca Ulshöfer; Helena Bros; Anja Erika Hauser; Raluca Aura Niesner; Friedemann Paul
Journal:  Oxid Med Cell Longev       Date:  2022-05-24       Impact factor: 7.310

Review 5.  SOD1 in ALS: Taking Stock in Pathogenic Mechanisms and the Role of Glial and Muscle Cells.

Authors:  Caterina Peggion; Valeria Scalcon; Maria Lina Massimino; Kelly Nies; Raffaele Lopreiato; Maria Pia Rigobello; Alessandro Bertoli
Journal:  Antioxidants (Basel)       Date:  2022-03-23

Review 6.  Morphological Heterogeneity of the Endoplasmic Reticulum within Neurons and Its Implications in Neurodegeneration.

Authors:  Sreesha Sree; Ilmari Parkkinen; Anna Their; Mikko Airavaara; Eija Jokitalo
Journal:  Cells       Date:  2021-04-21       Impact factor: 6.600

7.  Infant and adult SCA13 mutations differentially affect Purkinje cell excitability, maturation, and viability in vivo.

Authors:  Jui-Yi Hsieh; Brittany N Ulrich; Fadi A Issa; Meng-Chin A Lin; Brandon Brown; Diane M Papazian
Journal:  Elife       Date:  2020-07-09       Impact factor: 8.140

8.  A network biology approach to unraveling inherited axonopathies.

Authors:  Dana M Bis-Brewer; Matt C Danzi; Stefan Wuchty; Stephan Züchner
Journal:  Sci Rep       Date:  2019-02-08       Impact factor: 4.379

9.  Multi-Study Proteomic and Bioinformatic Identification of Molecular Overlap between Amyotrophic Lateral Sclerosis (ALS) and Spinal Muscular Atrophy (SMA).

Authors:  Darija Šoltić; Melissa Bowerman; Joanne Stock; Hannah K Shorrock; Thomas H Gillingwater; Heidi R Fuller
Journal:  Brain Sci       Date:  2018-12-04

10.  Mitochondria-associated membranes (MAMs) and pathologies.

Authors:  Paolo Pinton
Journal:  Cell Death Dis       Date:  2018-04-01       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.